| p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991 | 636 | 1991 |
| p53 mutation in hepatocellular carcinoma after aflatoxin exposure B Bressac, A Puisieux, M Kew, M Volkmann, S Bozcall, JB Mura, ... The Lancet 338 (8779), 1356-1359, 1991 | 636 | 1991 |
| Growth inhibition of hepatoma cells induced by vitamin K and its analogs Y Nishikawa, BI Carr, M Wang, S Kar, F Finn, P Dowd, ZB Zheng, J Kerns, ... Journal of Biological Chemistry 270 (47), 28304-28310, 1995 | 250 | 1995 |
| Bioactive food components and cancer risk reduction SD Stan, S Kar, GD Stoner, SV Singh Journal of cellular biochemistry 104 (1), 339-356, 2008 | 222 | 2008 |
| Entry of Bartonella bacilliformis into erythrocytes IGM Benson LA, Kar S, McLaughlin G Infection and Immunity 54 (2), 347-353, 1986 | 161 | 1986 |
| Detection of liver cells in peripheral blood of patients with advanced‐stage hepatocellular carcinoma S Kar, BI Carr Hepatology 21 (2), 403-407, 1995 | 136 | 1995 |
| Antitumor Activity of JS-K [O2-(2,4-Dinitrophenyl) 1-[(4-Ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and Related O2-Aryl Diazeniumdiolates in Vitro … PJ Shami, JE Saavedra, CL Bonifant, J Chu, V Udupi, S Malaviya, BI Carr, ... Journal of medicinal chemistry 49 (14), 4356-4366, 2006 | 133 | 2006 |
| Role of reactive oxygen intermediates in cellular responses to dietary cancer chemopreventive agents J Antosiewicz, W Ziolkowski, S Kar, AA Powolny, SV Singh Planta medica 74 (13), 1570-1579, 2008 | 128 | 2008 |
| Design and development of pilus vaccines for Haemophilus influenzae diseases CC Brinton Jr, MJ CARTER, DANB DERBER, S KAR, JA KRAMARIK, ... The pediatric infectious disease journal 8 (1), S62, 1989 | 92 | 1989 |
| Transient and sustained ERK phosphorylation and nuclear translocation in growth control T Adachi, S Kar, M Wang, BI Carr Journal of cellular physiology 192 (2), 151-159, 2002 | 91 | 2002 |
| JS‐K, a novel non‐ionic diazeniumdiolate derivative, inhibits Hep 3B hepatoma cell growth and induces c‐Jun phosphorylation via multiple MAP kinase pathways Z Ren, S Kar, Z Wang, M Wang, JE Saavedra, BI Carr Journal of cellular physiology 197 (3), 426-434, 2003 | 73 | 2003 |
| Binding and inhibition of Cdc25 phosphatases by vitamin K analogues S Kar, IM Lefterov, M Wang, JS Lazo, CN Scott, CS Wilcox, BI Carr Biochemistry 42 (35), 10490-10497, 2003 | 59 | 2003 |
| K vitamins, PTP antagonism, and cell growth arrest BI Carr, Z Wang, S Kar Journal of Cellular Physiology 193 (3), 263-274, 2002 | 54 | 2002 |
| PM-20, a novel inhibitor of Cdc25A, induces extracellular signal–regulated kinase 1/2 phosphorylation and inhibits hepatocellular carcinoma growth in vitro and in vivo S Kar, M Wang, W Yao, CJ Michejda, BI Carr Molecular cancer therapeutics 5 (6), 1511-1519, 2006 | 52 | 2006 |
| Differentially expressed genes in TGF-β1 sensitive and resistant human hepatoma cells D Sun, S Kar, BI Carr Cancer letters 89 (1), 73-79, 1995 | 49 | 1995 |
| Involvement of Cdc25A phosphatase in Hep3B hepatoma cell growth inhibition induced by novel K vitamin analogs Z Wang, EC Southwick, M Wang, S Kar, KS Rosi, CS Wilcox, JS Lazo, ... Cancer research 61 (19), 7211-7216, 2001 | 47 | 2001 |
| Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK S Kar, M Wang, SW Ham, BI Carr Biochemical pharmacology 72 (10), 1217-1227, 2006 | 45 | 2006 |
| Stimulation of hepatocyte DNA synthesis by neurotensin K Hasegawa, S Kar, BI Carr Journal of cellular physiology 158 (2), 215-222, 1994 | 43 | 1994 |
| Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties VP Peyregne, S Kar, SW Ham, M Wang, Z Wang, BI Carr Molecular cancer therapeutics 4 (4), 595-602, 2005 | 42 | 2005 |
| Growth inhibition and protein tyrosine phosphorylation in MCF 7 breast cancer cells by a novel K vitamin S Kar, BI Carr Journal of cellular physiology 185 (3), 386-393, 2000 | 40 | 2000 |
